openPR Logo
Press release

Toxoplasmosis Treatment Market Size to Achieve USD 1.09 billion by 2031, Fueled by a CAGR of 4.8%: Says Allied Market Research

05-07-2024 04:33 PM CET | Health & Medicine

Press release from: Allied Market Research (AMR)

Toxoplasmosis Treatment Market

Toxoplasmosis Treatment Market

Toxoplasmosis is an infection caused by common parasite, which is found in cat feces and in contaminated food. This parasite is known as Toxoplasma gondii. The symptoms of toxoplasmosis disease include body aches and pain, headache, fatigue, fever, and swollen lymph nodes. In addition, people with weakened immune system who receive chemotherapy, a previous toxoplasma infection may reactivate and cause the symptoms such as headache, confusion, poor coordination, and seizures.

Allied Market Research has just completed and published a study report with the title Toxoplasmosis Treatment Market Size was Valued at USD 683.1 million in 2021 and is Projected to Garner USD 1.09 billion by 2031, registering a CAGR of 4.8% from 2022 to 2031. The report provides an extensive analysis of changing market dynamics, major segments, value chains, competitive scenarios, and regional landscape. This research offers valuable guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining a competitive edge in the market.

Covid-19 Scenario

β€’ The outbreak of the COVID-19 pandemic had a negative impact on the global toxoplasmosis treatment market, as it disrupted workflows in the healthcare sector across the world.
β€’ The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care.
β€’ There had been a significant decrease in demand for toxoplasmosis during the pandemic. The significant reduction in clinical trials for toxoplasmosis treatment, owing to strict government guidelines against COVID-19 hampered the market growth. Decline in hospital visits, closing of borders, and confinement of the population affected the supply chains of these life-saving medical products in the toxoplasmosis treatment industry.
β€’ However, the market has now been able to recover slowly and steadily.
Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/16016

π–π‘πšπ­ 𝐚𝐫𝐞 𝐭𝐑𝐞 π‘πžπœπžπ§π­ π“π«πžπ§ππ¬ 𝐒𝐧 𝐭𝐑𝐞 𝐓𝐨𝐱𝐨𝐩π₯𝐚𝐬𝐦𝐨𝐬𝐒𝐬 π“π«πžπšπ­π¦πžπ§π­ 𝐌𝐚𝐫𝐀𝐞𝐭?

Increase in awareness about foodborne illness, surge in government support for healthcare infrastructure, rise in parasitic infection, and upsurge in use of Dara prim drug for the treatment of toxoplasmosis infections drive the growth of the global toxoplasmosis treatment market. However, side effects toxoplasmosis drugs such as toxic epidermal necrolysis, erythema multiforme, and hyperphenylalaninemia hinder the market growth. Moreover, rise in product launches for the treatment of toxoplasmosis disease is projected to provide the beneficial opportunities for toxoplasmosis treatment market growth.

Top Companies Of Toxoplasmosis Treatment:-

β€’ Alvogen
β€’ Dr Reddy's Laboratories Ltd.
β€’ Teva Pharmaceutical Industries Limited
β€’ Vyera Pharmaceuticals LLC
β€’ Mangalam Drugs and Organics Ltd.
β€’ Oakrum Pharma
β€’ Kaiser Permanente
β€’ Zorish Healthcare Private Limited
β€’ Omicron pharmaceuticals
β€’ Manus Aktteva Biopharma LLP
Toxoplasmosis Treatment Market Size Segmentation: -

By Type

β€’ Acquired Toxoplasmosis
β€’ Congenital Toxoplasmosis

By Route of Administration

β€’ Oral
β€’ Parenteral

By Distribution Channel

β€’ Hospital Pharmacies
β€’ Drug Stores and Retail Pharmacies
β€’ Online Providers
Based on region, North Americaβ€―held the highest market share in terms of revenue in 2021, accounting for nearly two-fifths of the global toxoplasmosis treatment market, and is likely to dominate the market during the forecast period, owing to rise in cases of parasitic infection cause the toxoplasmosis disease. However, the Asia-Pacificβ€―region is expected to witness the fastest CAGR of 5.5% from 2022 to 2031. Increase in spending capabilities, owing to rise in awareness programs for toxoplasmosis disease.

Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/16016

Our Market Research Solution Provides You Answer to Below Mentioned Question:

β€’ Which are the driving factors responsible for the growth of market?
β€’ Which are the roadblock factors of this market?
β€’ What are the new opportunities, by which market will grow in coming years?
β€’ What are the trends of this market?
β€’ Which are main factors responsible for new product launch?
β€’ How big is the global & regional market in terms of revenue, sales and production?
β€’ How far will the market grow in forecast period in terms of revenue, sales and production?
β€’ Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
β€’ How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
β€’ Which region has more opportunities?

By Region Outlook

North America
(U.S., Canada, Mexico)
Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Toxoplasmosis Treatment Market Size to Achieve USD 1.09 billion by 2031, Fueled by a CAGR of 4.8%: Says Allied Market Research here

News-ID: 3487655 • Views: …

More Releases from Allied Market Research (AMR)

Online Music Streaming Market Demand will reach a value of US$ 24,711.3 million by 2027 at a CAGR of 12.34%
Online Music Streaming Market Demand will reach a value of US$ 24,711.3 million …
The global online music streaming market size is expected to reach $24,711.3 million by 2027 at a CAGR of 12.34% from 2021 to 2027. Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/11521 Online music streaming is a means of delivering music without downloading any file from the internet. Music is stored on the servers' database and is instantly transferred to the streamer or users' device in real…
Low-E Glass Market Growth Trends: Global Analysis of Leading Players and Business Development Forecast to 2032
Low-E Glass Market Growth Trends: Global Analysis of Leading Players and Busines …
According to the study, the global low-e glass market was valued at $11.9 billion in 2022 and is projected to reach $21.0 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A15849 Market Drivers and Challenges: - The growing emphasis on energy efficiency and cost reduction is propelling the demand for low-emissivity (Low-E) glass globally. Despite higher upfront costs compared to traditional glass,…
Sunflower Lecithin Market: Industry Development Challenges, Opportunities & Key Manufacturers Analysis to 2032
Sunflower Lecithin Market: Industry Development Challenges, Opportunities & Key …
According to the report, the global sunflower lecithin market was valued at $324.6 million in 2018 and is projected to reach $754.8 million by 2032, growing at a CAGR of 5.7% from 2023 to 2032. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A156654 What is Sunflower Lecithin? Sunflower lecithin is a natural lipid blend derived from sunflower seeds, either mechanically or chemically, and is prized for its superior emulsifying and stabilizing properties. Composed primarily…
Bio-Renewable Chemicals Companies Analysis and Developments by 2031
Bio-Renewable Chemicals Companies Analysis and Developments by 2031
According to the report, the global bio-renewable chemicals market was valued at $2.5 billion in 2021 and is projected to reach $7.4 billion by 2031, registering a CAGR of 11.6% from 2022 to 2031. The study provides an in-depth analysis of market dynamics, emerging trends, key investment areas, value chains, regional insights, and competitive landscapes. Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/156 Market Drivers, Restraints, and Opportunities Drivers: - Technological advancements and innovations in…

All 5 Releases


More Releases for Toxoplasmosis

Toxoplasmosis Testing Market Insights, Forecast to 2031
"Toxoplasmosis Testing Market 2024," The objectives outlined in the report are multifaceted and aimed at offering a comprehensive understanding of the Toxoplasmosis Testing market dynamics. These objectives encompass a meticulous analysis and forecast of the market's dimensions, encompassing both its value and volume aspects. Additionally, the report seeks to discern and delineate the market shares held by major segments within the Toxoplasmosis Testing industry, providing stakeholders with a nuanced perspective on…
Toxoplasmosis Treatment Drugs Market Key Trends And Forecast Report 2024-2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company offers in-depth market insights through Toxoplasmosis Treatment Drugs Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The toxoplasmosis treatment drugs market size has grown strongly in recent…
Global Toxoplasmosis Testing Market Research Report 2023-2029
The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection. Global Toxoplasmosis Testing Market: Driven factors and Restrictions factors The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different…
How Drugs For Toxoplasmosis Market Development is Changing Business Needs?
Drugs For Toxoplasmosis Market Study 2022-2027: Drugs For Toxoplasmosis Market (Newly published report) which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), and Consumption Analysis, and focuses on various products and other market trends. The market research report on the global Drugs For Toxoplasmosis industry provides a comprehensive study of the various techniques and materials used in the production of Drugs For Toxoplasmosis market products. Starting from industry chain…
Technological Apogee To Catalyze The Toxoplasmosis Testing Market
Toxoplasmosis is an infection induced by Toxoplasma gondii parasite. Mostly cats serve as reservoir for this parasite. Based on the 2017 disease data from European Centre for Disease Prevention and Control, countries including Poland, United Kingdom and Germany had comparatively higher number of reported cases of congenital toxoplasmosis in infants creating a need for preventive measures to be taken for toxoplasmosis testing. This disease is transmitted through improper cooked meat consumption,…
Toxoplasmosis Diagnostic Testing Market: Evolving market trends and dynamics
Toxoplasmosis is an infectious disease caused by protozoan parasite Toxoplasma gondii, one of the world’s most dreaded parasite. There are 3 major genotypes of Toxoplasma gondii, namely (type 1, type 2, and type 3). These genotypes differ in their pathogenicity and prevalence among people around the world. Toxoplasmosis may be caused by transmission of T.gondii parasite through open wounds, consumption of contaminated raw meat, mutton, pork, beef, or by transfusion…